SCHEMBL20175460

SCHEMBL20175460

Cc1cccc(C(=O)N/N=C/c2ccc(N(C)C)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.74
KMT2A Q03164 6/20 0.74
ALDH1A1 P00352 5/20 0.74
NPC1 O15118 4/20 0.74
RAB9A P51151 4/20 0.74
SMN1; SMN2 Q16637 3/20 0.74
PKM P14618 1/20 0.74
HDAC8 Q9BY41 2/20 0.67
HDAC6 Q9UBN7 2/20 0.67
ESRRG P62508 1/20 0.64
KDM4E B2RXH2 4/20 0.63
MCL1 Q07820 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
MPO P05164 1/20 0.63
POLB P06746 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
GFER P55789 1/20 0.61
LMNA P02545 2/20 0.60
MEN1 O00255 1/20 0.60
CYP1A2 P05177 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13497018 0.86 RAB9A (0.72) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL17832049 0.86 MAPT (0.72) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL20175458 0.85 KMT2A (0.74) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL1563651 0.85 MAPT (1.00) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL6634490 0.85 MAPT (1.00) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL1563653 0.85 MAPT (1.00) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL27178216 0.84 SMN1; SMN2 (0.76) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL27178222 0.84 SMN1; SMN2 (0.76) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL30826121 0.84 SMN1; SMN2 (0.75) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL27178082 0.84 SMN1; SMN2 (0.75) MAPTKMT2AALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141897-A1 ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141897-A1 ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS LSS, ERG28, CYP51A1 MAPT 4055/4885KMT2A 3034/4885ALDH1A1 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.